Mexico’s ENCODAT 2025 finds smoking rate falls as vaping rises

Dec.25.2025
Mexico’s ENCODAT 2025 finds smoking rate falls as vaping rises
Results from Mexico’s ENCODAT 2025 indicate a structural shift in tobacco and nicotine use: past-month combustible tobacco use among the general population (ages 12–65) declined to 15.1%, down from 17.6% in 2016, while past-month e-cigarette use increased to 2.6%, up from 1.1%.

Key Points 

 

  • Clear structural shift: Mexico’s tobacco and nicotine use is showing a pattern of declining combustible tobacco use and rising e-cigarette use.
  • General population (ages 12–65): Past-month combustible tobacco use fell to 15.1% (from 17.6% in 2016), while past-month e-cigarette use rose to 2.6% (from 1.1% in 2016).
  • Gender differences: The decline in combustible tobacco use was driven mainly by men (27.1% → 22.8%), while women remained broadly stable (8.7% → 8.0%). E-cigarette use was higher among men (3.4%) than women (1.9%).
  • Adolescents (ages 12–17): Past-month combustible tobacco use dropped to 2.0% (from 4.9% in 2016), but past-month e-cigarette use increased to 3.1% (from 1.1% in 2016). The report notes no reported nicotine pouch use among this age group.
  • Adults (ages 18–65), product breakdown: Past-month use rates were 0.4% for smokeless tobacco, 0.5% for heated tobacco products (PTC), 2.6% for e-cigarettes, and 0.1% for nicotine pouches.

 


 

2Firsts, Dec. 25, 2025 —ENCODAT 2025 (Mexico’s National Survey on Drug, Alcohol and Tobacco Consumption) indicates a structural shift in tobacco and nicotine use: combustible tobacco use declined while e-cigarette use increased. 

 

The report notes that ENCODAT 2025 added specific questions to measure other tobacco products (including smokeless tobacco such as chewing tobacco/rapé/snus and heated tobacco products, PTC), and also incorporated emerging nicotine products such as e-cigarettes (vapeadores) and nicotine pouches. 

 

For the total population aged 12–65, last-month combustible tobacco use was 15.1%, down from 17.6% in 2016; the report attributes the reduction mainly to men (27.1% to 22.8%), while women remained essentially unchanged (8.7% to 8.0%).  Last-month e-cigarette use in the same 12–65 population was 2.6% (3.4% men, 1.9% women), up from 1.1% in 2016. 

 

Among adolescents aged 12–17, last-month combustible tobacco use fell from 4.9% in 2016 to 2.0% in 2025, with declines observed in both males and females (6.7% to 3.2% for males; 3.0% to 0.7% for females).  In contrast, last-month e-cigarette use among 12–17-year-olds was 3.1% (3.5% males, 2.6% females), higher than the 1.1% observed in 2016.  The report also states that no nicotine pouch use was reported in this age group. 

 

For adults aged 18–65, ENCODAT 2025 reports last-month use rates of 0.4% for smokeless tobacco, 0.5% for heated tobacco products (PTC), 2.6% for e-cigarettes, and 0.1% for nicotine pouches. 

 

Among combustible tobacco users aged 12–65, 74.8% reported interest in quitting; 57% made at least one quit attempt in the past year; and 16% stopped using combustible tobacco in the past year.  

 

The report also notes: health warnings on cigarette packs led 39.1% of smokers to think about quitting; pictorial warnings prevented smoking a cigarette in 27.1% of cases; offline advertising/promotion/sponsorship decreased from 37.6% (2016) to 32.3% (2025), while internet advertising/promotion/sponsorship increased from 17.6% to 27.3%.

 

Cover Image source: ChatGPT

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
The U.S. Food and Drug Administration (FDA) said its youth e-cigarette prevention campaign, “The Real Cost,” prevented about 444,000 U.S. youth from starting e-cigarette use between 2023 and 2024 and blocked more than $42 million in unauthorized e-cigarette sales that would have been used by youth.
Market
Jun.25
BP, Marathon and Valero Warn U.S. Gas-Station Stores: Illegal Vape Sales Could Bring Heavy Fines and Card-Processing Limits
BP, Marathon and Valero Warn U.S. Gas-Station Stores: Illegal Vape Sales Could Bring Heavy Fines and Card-Processing Limits
Fiserv and service station operators including BP, Marathon Petroleum and Valero have warned U.S. partners and gas-station convenience-store owners that selling illegal vapes could lead to heavy fines, breach brand agreements and even put stores’ card-processing access at risk, according to Reuters.
Regulations
Jul.07 by 2Firsts Perspectives
JT’s Ploom Volumes Rise 43.5% as Cigarettes Anchor Its Transition
JT’s Ploom Volumes Rise 43.5% as Cigarettes Anchor Its Transition
JT’s Ploom heated-tobacco volumes rose 43.5% in the first half of 2026, while combustibles still represented about 97% of its tobacco volume and remained the main earnings base. In Japan, reduced-risk products now account for 48.7% of industry shipments, shifting competition from category adoption towards brand share, pricing and consumer retention. JT’s results offer a revealing case of a traditional tobacco company pursuing a prolonged, dual-track transformation.
JTI
Jul.30
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
UK Councils Seize More Than 1.3 Million Non-Compliant Vapes One Year After Disposable Ban
UK Councils Seize More Than 1.3 Million Non-Compliant Vapes One Year After Disposable Ban
One year after the UK disposable vape ban came into force, local authorities continue to seize illegal and non-compliant vaping products. FOI data compiled by nicotine retailer Northerner shows more than 1.3 million products were seized between June 2025 and May 2026, with Bolton recording the highest number of seizures and Swansea reporting the highest estimated value.
Jul.21